References:
1. American Society for Reproductive Medicine (ASRM). Patient Management and Clinical Recommendations During the Coronavirus (COVID-19) Pandemic. https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/covid-19/covidtaskforce.pdf. Accessed 25.05.2020.
2. ESHRE Guidance on Recommencing ART Treatments. https://www.eshre.eu/Home/COVID19WG. Accessed 25.05.2020.
3. Updated Treatment Policy in Light of COVID-19 Updated April 29, 2020. https://www.embryo.net/covid19. Accessed 25.05.2020.
4. Liu W, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J 2020;133:00–00. doi: 10.1097/CM9.0000000000000775
5. Jordan RE, et al. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198. Published 2020 Mar 26. doi:10.1136/bmj.m1198
6. Wu Z, et al. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention [published online ahead of print, 2020 Feb 24]. JAMA. 2020;10.1001/jama.2020.2648. doi:10.1001/jama.2020.2648
7. Huang R, et al. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study. PLoS Negl Trop Dis. 2020;14(5):e0008280. Published 2020 May 8. doi:10.1371/journal.pntd.0008280
8. Wang D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [published online ahead of print, 2020 Feb 7]. JAMA. 2020;323(11):1061‐1069. doi:10.1001/jama.2020.1585
9. Wang X, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A Systemic Review and Meta-Analysis. Research (Wash D C). 2020;2020:2402961. Published 2020 Apr 19. doi:10.34133/2020/2402961
10. Monteleone G, et al. Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? [published online ahead of print, 2020 Mar 26]. J Crohns Colitis. 2020;jjaa061. doi:10.1093/ecco-jcc/jjaa061
11. Lebwohl M, et al. Should biologics for psoriasis be interrupted in the era of COVID-19?. J Am Acad Dermatol. 2020;82(5):1217‐1218. doi:10.1016/j.jaad.2020.03.031
12. Hsu JJ, et al. COVID-19 in a high-risk dual heart and kidney transplant recipient [published online ahead of print, 2020 Apr 21]. Am J Transplant. 2020;10.1111/ajt.15936. doi:10.1111/ajt.15936
13. Alviggi C, et al. COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management. Reprod Biol Endocrinol. 2020;18(1):45. Published 2020 May 13. doi:10.1186/s12958-020-00605-z
14. Hantoushzadeh S, et al. Maternal death due to COVID-19 [published online ahead of print, 2020 Apr 28]. Am J Obstet Gynecol. 2020;S0002-9378(20)30516-0. doi:10.1016/j.ajog.2020.04.030
15. https://www.who.int/news-room/q-a-detai l/q-a-on-covid -19-pregnancy-child birth -and-breast feeding. Accessed 25.05.2020..
16. Chen N, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507‐513. doi:10.1016/S0140-6736(20)30211-7
17. China CDC Weekly: Vital Surveillances: The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China, 2020. The Novel Coronavirus Pneumonia Emergency Response Epidemiology. 2020; 2(8): 113-122.
18. Suba Z. Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients. J Pharm Pharm Sci. 2020;23(1):75‐85. doi:10.18433/jpps31069
19. Kovats S. Estrogen receptors regulate innate immune cells and signaling pathways. Cell Immunol. 2015;294(2):63‐69. doi:10.1016/j.cellimm.2015.01.018
20. Joo BS, et al. Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner. Fertil Steril. 2010;93(2): 442-6.
Table 1: Clinical Characteristics of the Participants